Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts.

about

Genetic architecture of human fibrotic diseases: disease risk and disease progression.A halotyrosine antibody that detects increased protein modifications in asthma patients.Early Detection of Urinary Proteome Biomarkers for Effective Early Treatment of Pulmonary Fibrosis in a Rat Model.

P2860

Q37400152-3FCF7580-781D-43A6-9855-CFE7D37B9222 Q37621763-D36DB82D-E536-472A-897D-2CA3FAA1D856 Q47448022-A7F5CE99-9911-4005-9953-4C656A20FC3B

P2860

Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts.

Item

http://www.wikidata.org/entity/Q35766650

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Angiotensinogen promoter polym ...... U.S. and Spanish IPF cohorts.

@ast

Angiotensinogen promoter polym ...... U.S. and Spanish IPF cohorts.

@en

type

Item

label

Angiotensinogen promoter polym ...... U.S. and Spanish IPF cohorts.

@ast

Angiotensinogen promoter polym ...... U.S. and Spanish IPF cohorts.

@en

prefLabel

Angiotensinogen promoter polym ...... U.S. and Spanish IPF cohorts.

@ast

Angiotensinogen promoter polym ...... U.S. and Spanish IPF cohorts.

@en

P1476

Angiotensinogen promoter polym ...... U.S. and Spanish IPF cohorts.

@en

P2093

Antoni Xaubet

http://www.w3.org/2001/XMLSchema#string

Bruce D Uhal

http://www.w3.org/2001/XMLSchema#string

Chenyang Gu

http://www.w3.org/2001/XMLSchema#string

Jeannie I Klavanian

http://www.w3.org/2001/XMLSchema#string

Julio Ancochea

http://www.w3.org/2001/XMLSchema#string

Karen H Friderici

http://www.w3.org/2001/XMLSchema#string

Katherine A Jernigan

http://www.w3.org/2001/XMLSchema#string

Maria Molina-Molina

http://www.w3.org/2001/XMLSchema#string

My-Trang T Dang

http://www.w3.org/2001/XMLSchema#string

Yuehua Cui

http://www.w3.org/2001/XMLSchema#string

P2860

A simple salting out procedure for extracting DNA from human nucleated cells

Angiotensin II and the fibroproliferative response to acute lung injury.

Novel therapeutic approaches for pulmonary fibrosis.

Gender-based differences in bleomycin-induced pulmonary fibrosis.

Haplotypes of angiotensinogen in essential hypertension

Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression.

Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages.

JunD and HIF-1alpha mediate transcriptional activation of angiotensinogen by TGF-beta1 in human lung fibroblasts

A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.

Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells.

P2888

s00408-013-9476-2

P304

353-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00408-013-9476-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

191

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236958177

http://www.w3.org/2001/XMLSchema#string

P698

23715995

http://www.w3.org/2001/XMLSchema#string

P932

4476508

http://www.w3.org/2001/XMLSchema#string

Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts.

about

P2860

P2860

Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932